1. Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells in�vitro
    Hongbing Chen et al, 2018, Oncology Letters CrossRef
  2. ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
    Jing Cheng et al, 2022, Frontiers in Pharmacology CrossRef
  3. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway
    Yong Tang et al, 2024, BMC Cancer CrossRef
  4. ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer
    Margherita Sisto et al, 2021, Journal of Clinical Medicine CrossRef
  5. Proteolytic Landscapes in Gastric Pathology and Cancerogenesis
    Sabine Bernegger et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions
    Alberto Dinarello et al, 2023, Cells CrossRef
  7. Genomic Analysis Revealed Mutational Traits Associated with Clinical Outcomes in Osteosarcoma
    Xiying Chi et al, 2021, Cancer Management and Research CrossRef
  8. Immunomodulatory role of metalloproteinase ADAM17 in tumor development
    Kai Wang et al, 2022, Frontiers in Immunology CrossRef
  9. Modulatory effect of euxanthone in liver cancer-bearing obese mice: crosstalk between PPARγ and TIMP3 signalling axes
    Xu Wang et al, 2021, 3 Biotech CrossRef
  10. Construction of a novel immune-related prognostic-predicting model of gastric cancer
    Ting Pang et al, 2023, Gene CrossRef

  11. LncRNA LINC00689 Promotes the Progression of Gastric Cancer Through Upregulation of ADAM9 by Sponging miR-526b-3p


    Gang Yin et al, 2020, Cancer Management and Research CrossRef
  12. Exosome-Derived ADAM17 Promotes Liver Metastasis in Colorectal Cancer
    Jinbing Sun et al, 2021, Frontiers in Pharmacology CrossRef
  13. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis
    Danzan Mansorunov et al, 2021, Diagnostics CrossRef
  14. Integration of Pan-Cancer Single-Cell and Spatial Transcriptomics Reveals Stromal Cell Features and Therapeutic Targets in Tumor Microenvironment
    Yanhua Du et al, 2024, Cancer Research CrossRef
  15. A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
    Marta Łukaszewicz-Zając et al, 2022, Cancers CrossRef
  16. The metalloprotease ADAM17 in inflammation and cancer
    Stefan Düsterhöft et al, 2019, Pathology - Research and Practice CrossRef
  17. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway
    Junwen Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  18. MicroRNA‐224, negatively regulated by c‐jun, inhibits growth and epithelial‐to‐mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma
    Yaoyong Lu et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
  19. Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo
    Jie Ye et al, 2017, European Journal of Pharmaceutical Sciences CrossRef
  20. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways
    Wei Li et al, 2018, International Journal of Molecular Medicine CrossRef
  21. The anticipating value of PLK1 for diagnosis, progress and prognosis and its prospective mechanism in gastric cancer: a comprehensive investigation based on high-throughput data and immunohistochemical validation
    Peng Lin et al, 2017, Oncotarget CrossRef
  22. Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis
    Peng Ni et al, 2020, Medicina CrossRef
  23. Role of a disintegrin and metalloproteinase 17 in malignant tumors of the digestive system
    Rong Xu et al, 2020, World Chinese Journal of Digestology CrossRef
  24. Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures
    Bassil Dekky et al, 2018, Oncotarget CrossRef